Categories: News

First-in-Class Biologic Eye Drop Regener-Eyes Announces New Clinical Advisory Board Member Dr. Art Epstein

PALM HARBOR, FL / ACCESSWIRE / February 23, 2021 / Regener-Eyes®, a leading first-in-class biologic eye drop made of naturally-occurring cytokines and growth factors, today announced the addition of Dr. Art Epstein to its Clinical Advisory Board.

“We are excited to have Dr. Art Epstein join our clinical advisory board. He is a highly respected eye care professional, and will bring valuable insight to our company’s efforts,” commented C. Randall Harrell, M.D., CEO and Founder of Regener-Eyes®. “We are honored to add Dr. Epstein to our existing board alongside our other impressive members, Dr. Marguerite McDonald, Dr. Eric Donnenfeld, Dr. Paul Karpecki, Dr. Walt Whitley, Dr. Scott Schacter and Dr. Ahmed Fahmy.”

Dr. Epstein is the co-founder of Phoenix Eye Care, PLLC and he heads the practice’s Dry Eye – Ocular Surface Disease Center – The Dry Eye Center of Arizona and serves as its Director of Clinical Research. He is an Adjunct Associate Professor at Midwestern University Arizona College of Optometry. Active in the profession, Dr. Epstein is a fellow of the American Academy of Optometry and a Distinguished Practitioner of the National Academies of Practice. He is a Diplomate of the American Board of Certification in Medical Optometry, a member of the American and Arizona Optometric Associations and Past-Chair of the AOA Contact Lens & Cornea Section.

About Regener-Eyes®

Regener-Eyes® is a sterile biologic eye drop made of anti-inflammatory cytokines and growth factors. These types of proteins have been shown to reduce inflammation and stimulate the ocular surface to heal, repair, and regenerate. If you have patients that are not responding to current dry eye drugs, amniotic membrane intolerant, or having issues with blood serum tears, many physicians are finding success with Regener-Eyes® as a new option. For more information on our first in class biologic eye drop, please visit us at www.mydryeyes.org, follow us Instagram, like us on Facebook and connect with us on LinkedIn.

Contact Information:

Regener-Eyes®, LLC
Heidi Hart Pukas
heidi.pukas@regenerativeplant.org

SOURCE: Regener Eyes

View source version on accesswire.com:
https://www.accesswire.com/631505/First-in-Class-Biologic-Eye-Drop-Regener-Eyes-Announces-New-Clinical-Advisory-Board-Member-Dr-Art-Epstein

Staff

Recent Posts

Biolase Reports Full-Year 2023 Results; Expects Continued Revenue Growth In 2024

LAKE FOREST, CA / ACCESSWIRE / March 21, 2024 / BIOLASE, Inc. (NASDAQ:BIOL), the globally…

7 hours ago

Free Dementia Training in Alabama

Bring Dementia Education at No Cost to Your Skilled Nursing HomeTUSCALOOSA, AL / ACCESSWIRE /…

7 hours ago

Accuryn Medical Announces Maclean Health FSS Contract Award

Accuryn Monitor Now Included in Department of Veteran Affairs (VA) Federal Supply Schedule (FSS)HAYWARD, CA…

10 hours ago

Southern Illinois Associates Selects eClinicalWorks Cloud EHR for Comprehensive Behavioral Health Tools

The psychiatry and behavioral health group to utilize practice management and patient engagement solutions to…

13 hours ago

Nym Named Among Top 25 Companies in Healthcare Software for 2024 by The Healthcare Technology Report

NEW YORK--(BUSINESS WIRE)--Nym, the leader in autonomous medical coding, today announced that it has been…

13 hours ago